Premarket Movers: Micron, Forte, ExxonMobil, Baker Hughes See Significant Activity
Micron Technology and Forte Biosciences shares surged in premarket trading, while ExxonMobil declined due to easing geopolitical tensions. Baker Hughes stood out with strong second-quarter earnings, driven by AI demand, M&A activity, and shifts in the energy market.
As investors navigated a mixed global market sentiment, several key stocks made significant moves in premarket trading in the U.S. Micron Technology (MU) saw an uptick driven by robust artificial intelligence (AI) chip demand, while Forte Biosciences (FBRX) shares soared following a major acquisition announcement. Conversely, ExxonMobil (XOM) experienced a decline as crude oil prices fell amid easing geopolitical tensions in the Middle East, though Baker Hughes (BKR) posted strong second-quarter results.
Memory chip manufacturer Micron Technology gained over 3% in premarket trading, defying a bearish bet from investor Michael Burry. This surge is largely attributed to a positive outlook for AI memory chips and favorable analyst reports. Bernstein analysts highlighted that major AI companies are securing long-term supplies of high-bandwidth memory (HBM), which is expected to sustain strong demand. South Korea's substantial $950 billion AI investment plan further bolstered the sector. Additionally, a potential labor strike at rival Samsung could indirectly benefit Micron and other memory producers.
In the biotechnology sector, Forte Biosciences shares jumped by 39.2% in pre-open trading after Argenx (ARGX) announced a definitive agreement to acquire the clinical-stage biotech for approximately $2.2 billion in cash. Argenx will pay $77 per share for Forte Biosciences, representing a significant premium over its recent closing price. The acquisition is centered on Forte's lead program, FB102, an anti-CD122 antibody, which has shown positive Phase 1b data in both vitiligo and celiac disease. This strategic move is expected to expand Argenx's immunology portfolio, with the transaction anticipated to close in the third quarter of 2026.
The energy sector witnessed contrasting performances. ExxonMobil shares dropped nearly 3% in premarket trading as Brent crude oil prices plummeted over 8% to around $90 per barrel. This sharp decline followed reports that the United States and Iran had paused military operations over the weekend, with renewed diplomatic talks potentially on the horizon. The de-escalation of Middle East tensions removed the geopolitical risk premium that had previously buoyed oil prices, prompting investors to re-evaluate earnings expectations ahead of ExxonMobil's second-quarter 2026 earnings report scheduled for July 31. In contrast, oilfield services giant Baker Hughes saw its shares rise by approximately 2-3% in premarket trading after reporting robust second-quarter results that surpassed analyst expectations. The company announced adjusted earnings per share of $0.64, exceeding the consensus estimate of $0.49, and revenue of $6.74 billion, above the forecasted $6.52 billion. Record orders from its Industrial & Energy Technology (IET) segment, totaling $7.1 billion, coupled with strong demand from data centers, gas infrastructure, and upstream markets driven by energy security and AI needs, were cited by CEO Lorenzo Simonelli as key growth drivers.
These diverse stock movements underscore the varying influences of technological advancements in AI and biotechnology, along with the geopolitical and commodity price fluctuations affecting the energy sector. Significant investments in AI technologies and strategic mergers and acquisitions in drug development are rapidly boosting specific company valuations, while the energy market remains highly sensitive to global events. In an environment of increasing overall market risk appetite, sectoral dynamics play a decisive role in stock performance.
Analysts continue to maintain a strong outlook for Micron, anticipating sustained demand for AI chips for years to come and reinforcing the company's solid position in the high-bandwidth memory market. For Forte Biosciences, the Argenx acquisition is expected to accelerate the development of its FB102 program, with closing anticipated in the third quarter. ExxonMobil investors will closely monitor the impact of falling oil prices on the company's profit outlook ahead of its Q2 earnings report on July 31. Baker Hughes management remains confident in achieving the midpoint of its full-year guidance, buoyed by robust IET orders and AI-driven energy demand.
Related Symbols
💸 Ready to act on this news?
You need a brokerage account to invest. Compare 30+ trusted brokers in seconds — zero commission options available.
Comments (0)
No comments yet. Be the first to comment!